Abstract: Instrument control and data acquisition in advanced analytic systems that utilize optical pulses for sample analysis are described. Clocking signals for data acquisition, data processing, communication, and/or other data handling functionalities can be derived from an on-board pulsed optical source, such as a passively mode-locked laser. The derived clocking signals can operate in combination with one or more clocking signals from a stable oscillator, so that instrument operation and data handling can tolerate interruptions in operation of the pulsed optical source.

Abstract: Liquids to be dispensed as “frozen” or “slush” beverages are rapidly cooled to a suitable target viscosity or percentage of frozen, by maintaining a flow of liquid nitrogen through one or more heat exchangers, counterflowing the beverage to be cooled from a reservoir to a dispenser, and controlling the flow of liquid nitrogen to achieve the target viscosity or percentage of frozen of the beverage to be dispensed.

Abstract: Liquids to be dispensed as “frozen” or “slush” beverages are rapidly cooled to a suitable target viscosity or percentage of frozen, by maintaining a flow of liquid nitrogen through one or more heat exchangers, counterflowing the beverage to be cooled from a reservoir to a dispenser, and controlling the flow of liquid nitrogen to achieve the target viscosity or percentage of frozen of the beverage to be dispensed.

Abstract: Compounds of Formula I wherein X and R1-6, are as defined herein, tautomeric forms thereof, and isomeric forms thereof, and salts thereof, are suitable for treating diseases that are induced by the action of nitrogen monooxide at pathological concentration. Such diseases include neurodegenerative diseases, inflammatory diseases, auto-immune diseases, and cardiovascular diseases.

Abstract: This invention relates to novel tricyclic pteridinones, their aza analogs and their pharmaceutically acceptable salts. Further encompassed by the invention is a novel process for the production of the tricyclic pteridinones and their aza analogs. The compounds of the invention exhibit cardiovascular properties, particularly mixed vasodilation and selective venous and arterial dilation. Pharmaceutical compositions are proposed for the compounds.